A detailed history of Wakefield Asset Management Lllp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Wakefield Asset Management Lllp holds 6,859 shares of TMDX stock, worth $626,981. This represents 0.37% of its overall portfolio holdings.

Number of Shares
6,859
Previous 6,965 1.52%
Holding current value
$626,981
Previous $1.05 Million 2.57%
% of portfolio
0.37%
Previous 0.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$135.68 - $176.11 $14,382 - $18,667
-106 Reduced 1.52%
6,859 $1.08 Million
Q2 2024

Aug 05, 2024

BUY
$72.62 - $150.62 $505,798 - $1.05 Million
6,965 New
6,965 $1.05 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.91B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.